NEW YORK, June 1, 2021 /PRNewswire/ -- The antinuclear antibody (ANA) testing market is expected to grow by USD 362.30 million during 2021-2025, according to Technavio. The report offers a detailed analysis of the impact of the COVID-19 pandemic on the antinuclear antibody (ANA) testing market in optimistic, probable, and pessimistic forecast scenarios.
Technavio's in-depth market research reports include value chain analysis and validation techniques to help industry leaders improve their business. Download FREE Sample Report
The anti-nuclear antibody (ANA) testing market will witness a Neutral impact during the forecast period owing to the widespread growth of the COVID-19 pandemic. As per Technavio's pandemic-focused market research, market growth is likely to increase in 2021 as compared to 2020.
With the continuing spread of the novel coronavirus pandemic, organizations across the globe are gradually flattening their recessionary curve by leveraging technology. Many businesses will go through response, recovery, and renewal phases. Building business resilience and enabling agility will aid organizations to move forward in their journey out of the COVID-19 crisis towards the Next Normal.
This post-pandemic business planning research will aid clients to:
Adjust their strategic planning to move ahead once business stability kicks in.
Build Resilience by making effective resource and investment choices for individual business units, products, and service lines.
Conceptualize scenario-based planning to mitigate future crisis situations.
Impact of lockdowns, supply chain disruptions, demand destruction, and change in customer behavior
Optimistic, probable, and pessimistic scenarios for all markets as the impact of pandemic unfolds
Pre- as well as post-COVID-19 market estimates
Quarterly impact analysis and updates on market estimates
Major Three Anti-nuclear Antibody (ANA) Testing Market Participants:
Abbott Laboratories offers a covid-19 antibody test. Its test helps to detect IgG antibodies to SARS-CoV-2.
Abcam Plc offers anti-ENA Screen Human in vitro ELISA (Enzyme-Linked Immunosorbent Assay) kit. It is designed for the accurate semi-quantitative measurement of IgG class antibodies against extractable nuclear antigens: Sm (Smith), RNP/Sm, Scl-70, SS-A (Ro) (52kDa and 60kDa), SS-B (La), Jo-1, in Human serum or plasma.
Bio-Rad Laboratories Inc.
Bio-Rad Laboratories Inc. offers the product named HEp-2 IFA. it is a kit used for the detection of antinuclear antibodies using indirect immunofluorescence. It also offers ANA and ENA assays for detection of antinuclear antibodies associated with systemic rheumatic diseases; also for identification of specific autoantibodies.
The anti-nuclear antibody (ANA) testing market is segmented as below:
Clinical Diagnostic Laboratories
The anti-nuclear antibody (ANA) testing market is driven by the increasing number of autoimmune diseases. In addition, the advances in laboratory automation platforms are expected to trigger the anti-nuclear antibody (ANA) testing market toward witnessing a CAGR of about 7% during the forecast period.
Global Influenza Diagnostics Market- The influenza diagnostics market is segmented by end-user (hospitals and diagnostic laboratories, academic and research centers, and homecare), type (point-of-care testing, immunodiagnostics, and molecular diagnostics), and geography (North America, Europe, Asia, and ROW). Download FREE Sample Report
Global Antimicrobial Susceptibility Testing Market- The antimicrobial susceptibility testing market is segmented by application (clinical diagnostics, drug discovery and development, and others) and geography (North America, Europe, Asia, and ROW). Download FREE Sample Report
Market positioning of vendors
About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.